About this episode

This episode discusses strategies for implementing Antibody-Drug Conjugates in oncology nursing, featuring expert perspectives on various ADCs for different cancers.

Featuring perspectives from Ms Courtney Arn, Ms Jamie Carroll, Dr Edward B Garon, Dr Heather McArthur and Dr Kathleen N Moore, moderated by Dr Moore, including the following topics: Introduction (0:00) Overview of Antibody-Drug Conjugates (ADCs) (2:07) Current and Future Role of HER2-Targeted ADCs for Breast Cancer (6:23) Currently Available ADCs for Gynecologic Cancer Management (26:37) Currently Available ADCs for Lung Cancer Management (44:07) Current and Future Role of TROP2-Targeted ADCs for Metastatic Breast Cancer (56:55) Other ADCs That May Soon Reach the Clinic for Advanced Gynecologic Cancers (1:15:07) Promising Investigational Strategies Employing ADCs for Lung Cancer (1:25:01) NCPD information and select publications

People in this episode

Host: Dr Moore

Guests: Ms Courtney Arn, Ms Jamie Carroll, Dr Edward B Garon, Dr Heather McArthur, Dr Kathleen N Moore

Topics covered

• Antibody-Drug Conjugates
• Breast Cancer
• Gynecologic Cancer
• Lung Cancer
• Oncology Nursing
• HER2-Targeted Therapies
• TROP2-Targeted Therapies

Keywords

• Antibody-Drug Conjugates
• HER2-Targeted ADCs
• TROP2-Targeted ADCs
• Breast Cancer
• Gynecologic Cancer
• Lung Cancer
• Oncology Nursing
• ADC Management
• Metastatic Breast Cancer

Mentioned in this episode

Organizations: ONS Congress

Products: Antibody-Drug Conjugates, HER2-Targeted ADCs, TROP2-Targeted ADCs, ADCs

Places: Breast Cancer, Gynecologic Cancer, Lung Cancer, Metastatic Breast Cancer

More episodes of Breast Cancer Update

• HER2-Positive Metastatic Breast Cancer — An Interview with Prof Dr Sibylle Loibl on First-Line and Maintenance Therapy · July 18, 2026 · 46 min
• Localized HR-Positive Breast Cancer — Year in Review Series on Relevant New Datasets and Advances · July 13, 2026 · 58 min
• Antibody-Drug Conjugates in the Management of Breast Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting · July 8, 2026 · 2h 0m
• HR-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit · June 29, 2026 · 1h 39m
• Metastatic Triple-Negative Breast Cancer — What Clinicians Want to Know · June 26, 2026 · 54 min
• HER2-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit · June 23, 2026 · 52 min

Explore listener stats, chart rankings, contacts and more on the Breast Cancer Update podcast page.